Drexel Morgan & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.46M Hold
28,820
0.36% 34
2025
Q4
$2.28M Hold
28,820
0.36% 33
2025
Q3
$2.3M Hold
28,820
0.36% 31
2025
Q2
$2.62M Hold
28,820
0.47% 30
2025
Q1
$2.7M Hold
28,820
0.57% 26
2024
Q4
$2.62M Hold
28,820
0.54% 27
2024
Q3
$2.99M Hold
28,820
0.56% 28
2024
Q2
$2.8M Hold
28,820
0.6% 26
2024
Q1
$2.6M Hold
28,820
0.53% 26
2023
Q4
$2.3M Hold
28,820
0.53% 28
2023
Q3
$2.05M Buy
28,820
+675
+2% +$50.5K 0.56% 27
2023
Q2
$2.17M Hold
28,145
0.56% 28
2023
Q1
$2.12M Hold
28,145
0.53% 28
2022
Q4
$2.22M Buy
28,145
+650
+2% +$48.7K 0.46% 27
2022
Q3
$1.93M Hold
27,495
0.46% 27
2022
Q2
$2.2M Hold
27,495
0.61% 26
2022
Q1
$2.08M Hold
27,495
0.61% 25
2021
Q4
$2.35M Hold
27,495
0.68% 24
2021
Q3
$2.08M Hold
27,495
0.67% 27
2021
Q2
$2.24M Hold
27,495
0.66% 31
2021
Q1
$2.17M Hold
27,495
0.55% 37
2020
Q4
$2.35M Hold
27,495
0.64% 34
2020
Q3
$2.12M Sell
27,495
-3,141
-10% -$239K 0.75% 36
2020
Q2
$2.24M Buy
30,636
+34
+0.1% +$2.42K 0.85% 28
2020
Q1
$2.03M Buy
30,602
+7,402
+32% +$522K 0.79% 30
2019
Q4
$1.6M Sell
23,200
-4,144
-15% -$283K 1.2% 32
2019
Q3
$2.01M Sell
27,344
-11
-0% -$798 1.55% 24
2019
Q2
$1.96M Buy
27,355
+618
+2% +$43.9K 1.51% 25
2019
Q1
$1.83M Buy
26,737
+758
+3% +$49K 1.63% 25
2018
Q4
$1.55M Buy
25,979
+652
+3% +$40.8K 1.55% 28
2018
Q3
$1.7M Buy
25,327
+369
+1% +$24.6K 1.49% 28
2018
Q2
$1.62M Buy
24,958
+1,819
+8% +$119K 1.62% 25
2018
Q1
$1.66M Buy
23,139
+184
+0.8% +$13.2K 1.73% 24
2017
Q4
$1.73M Buy
22,955
+381
+2% +$27.8K 1.68% 23
2017
Q3
$1.65M Sell
22,574
-533
-2% -$38.4K 1.69% 21
2017
Q2
$1.71M Buy
23,107
+287
+1% +$21.3K 1.76% 20
2017
Q1
$1.67M Buy
22,820
+2,596
+13% +$182K 1.85% 15
2016
Q4
$1.32M Hold
20,224
1.57% 23
2016
Q3
$1.5M Hold
20,224
1.66% 17
2016
Q2
$1.48M Sell
20,224
-631
-3% -$44.9K 1.68% 16
2016
Q1
$1.47M Buy
20,855
+178
+0.9% +$11.8K 1.73% 16
2015
Q4
$1.38M Buy
20,677
+147
+0.7% +$9.78K 1.53% 17
2015
Q3
$1.3M Buy
20,530
+891
+5% +$58.2K 1.68% 16
2015
Q2
$1.28M Buy
19,639
+241
+1% +$16.3K 1.52% 18
2015
Q1
$1.34M Buy
19,398
+146
+0.8% +$10.1K 1.44% 17
2014
Q4
$1.33M Hold
19,252
1.5% 17
2014
Q3
$1.26M Buy
19,252
+488
+3% +$32.2K 1.53% 19
2014
Q2
$1.28M Sell
18,764
-180
-1% -$12.1K 1.55% 19
2014
Q1
$1.23M Hold
18,944
1.55% 18
2013
Q4
$1.24M Sell
18,944
-3,035
-14% -$194K 1.67% 17
2013
Q3
$1.3M Buy
21,979
+6,725
+44% +$398K 1.79% 15
2013
Q2
$874K Buy
+15,254
New +$905K 1.45% 20

Other funds holding CL

Drexel Morgan & Co's CL Position: Q1 2026 in Review

Drexel Morgan & Co held its Colgate-Palmolive (CL) position steady in Q1 2026 at 28,820 shares worth $2.46M. The position accounts for 0.36% of the portfolio, ranked #34.

Drexel Morgan & Co first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.99M in Q3 2024. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Drexel Morgan & Co held 28,820 shares of Colgate-Palmolive worth $2.46M as of Q1 2026.
  • Drexel Morgan & Co left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.36% of Drexel Morgan & Co's portfolio in Q1 2026, its #34 holding.
  • Drexel Morgan & Co first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Drexel Morgan & Co's Colgate-Palmolive position peaked at $2.99M in Q3 2024.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Drexel Morgan & Co's 13F filing for Q1 2026, filed 11 May 2026.